Personalized Blood Flow Restriction for Anterior Cruciate Ligament Rehabilitation
NCT ID: NCT04635579
Last Updated: 2022-02-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2018-05-08
2020-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Blood Flow Restriction Therapy Following ACL Tear
NCT04374968
Blood Flow Restriction Following ACL Reconstruction
NCT03758755
The Impact of Blood Flow Restriction Training in Adolescents After ACL Reconstruction: A Randomized Controlled Trial
NCT05754632
BFR Therapy After ACL Reconstruction
NCT03794570
Effects of Blood Flow Restriction Rehabilitation After Anterior Cruciate Ligament Reconstruction
NCT04484961
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anterior cruciate ligament reconstruction group
Single session blood flow restriction of lower limb to individuals who have undergone anterior ligament reconstruction surgery
Blood flow restriction
Intervention restricts blood flow to the lower limb as a percentage of the limb occlusion pressure
Control group
Single session blood flow restriction of lower limb to individuals who have no musculoskeletal injuries
Blood flow restriction
Intervention restricts blood flow to the lower limb as a percentage of the limb occlusion pressure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood flow restriction
Intervention restricts blood flow to the lower limb as a percentage of the limb occlusion pressure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be at least 3 months post surgery.
* Attending clinician should confirm that they are able to take part in the trial
Exclusion Criteria
* Any medical conditions that may affect circulation including, but not limited to, deep vein thrombosis, high blood pressure, and cardiac disease
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Scott Telfer, EngD
Assistant Professor: School of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott Telfer, EngD
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Washington Medical Center
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00004543
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.